Updates in Therapeutics for Parkinson’s Disease

The speaker was Gaurav Chattree, MD, movement disorder specialist at Stanford. He addressed the "phase 3" or "almost phase 3" research pipeline for disease-modification treatments and for symptomatic therapies. Visit the Palo Alto Parkinson's Support Group https://med.stanford.edu/parkinsons/n... Stanford's APDA Information & Referral Center and Stanford Parkinson's Community Outreach coordinate a local Parkinson's Disease (PD) support group in Palo Alto. Since March 2021, we meet virtually, highlighting local resources, Stanford healthcare professionals, and Stanford research.